Board
A Board blending senior scientific, regulatory, business and financing experience to support the strategic direction of X’PROCHEM

Jean-François Grenier, M.D., D.A.
Dr. Jean-Francois Grenier is a seasoned executive from the bio-pharmaceutical industry. Trained as a Medical Doctor in Canada, he also earned a graduate diploma in

Guillaume Bruniaux, M.Sc Economics & Finance
Mr. Guillaume Bruniaux is Project Director at « Nord France Amorçage » or « NFA », a Public Investment Capital fund of « Région Hauts-de-France ». NFA, which is managed by

Elisabeth Baumelou-Torck, M.D.
Dr. Elisabeth Baumelou-Torck is a physician specialized in hematology and oncology with extensive clinical and research experience. Dr. Baumelou-Torck founded the Hemato-Oncology Department of Foch

Jacques Bourjot, Ing.
Mr. Jacques Bourjot is an Engeneer,who graduated from “Arts & Métiers”. He has dedicated large parts of his professional life to community building projects with

Hervé Vanderhaegen, M.Sc. Economics
Mr. Hervé Vanderhaegen is a Private Equity manager since 1991.He is currently board member of IRD Gestion, a leading actor in the economic development of